Added to YB: 2024-03-03
Pitch date: 2024-03-03
MNKD:US [bullish]
MannKind Corporation
+29.13%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of therapeutic products and services for endocrine and orphan lung diseases in the United States.
Market Cap
$1.6B
Pitch Price
$4.60
Price Target
N/A
Dividend
N/A
EV/EBITDA
17.21
P/E
51.69
EV/Sales
4.84
Sector
Biotechnology
Category
N/A
Show full summary:
MannKind Corporation MNKD:US
A summary for this pitch has not been created yet.
Read full article (0 min)